ASCO is leading efforts to reduce drug shortages by convening parties across the cancer community focused on finding solutions to the drug shortage crisis. This session reviews potential market/economic factors that can improve resiliency in the sterile injectable drug market and discuss potential policy changes to help mitigate future cancer drug shortages. These events are in addition to ASCO’s robust and long-established work advocating US Congress to pass comprehensive policy solutions to end cancer drug shortages.